Durham, NC, United States of America

Bobby Neal Glover

This inventor holds 6 USPTO granted patents and 5 published patent applications. Top assignees: Glaxosmithkline LLC, Smithkline Beecham Corporation. Active years: 2002-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bobby Neal Glover. Retrieved from https://idiyas.com/inventor/bobby-neal-glover

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 50.0

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 49(Granted Patents)


Location History:

  • Cary, NC (US) (2002)
  • Durham, NC (US) (2007 - 2015)

Company Filing History:


Years Active: 2002-2015

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Bobby Neal Glover: Innovator in Antiviral Compounds

Introduction

Bobby Neal Glover is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. With a total of 6 patents, Glover's work has had a meaningful impact on medical therapy.

Latest Patents

Glover's latest patents focus on crystalline forms of an antiviral benzimidazole compound. The inventions relate to crystalline forms of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole. These patents also cover pharmaceutical compositions comprising the same, processes for preparing the same, and their use in medical therapy.

Career Highlights

Throughout his career, Glover has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and GlaxoSmithKline LLC. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Glover has collaborated with notable coworkers such as Lian-Feng Huang and Robert William Lancaster. These partnerships have likely enhanced his research and development efforts in the field of antiviral compounds.

Conclusion

Bobby Neal Glover's contributions to antiviral research and his impressive portfolio of patents underscore his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…